BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2495618)

  • 1. Kinetics of increased class II antigen expression in canine pancreas allograft rejection.
    Ekberg H; Allen RD; Chapman JR; Hawthorne WJ; Williamson P; Grierson JM; Stewart GJ; Little JM
    Transplant Proc; 1989 Feb; 21(1 Pt 1):510-2. PubMed ID: 2495618
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo immunosuppressive effect and the decreasing expression of MHC class II antigens by purine nucleoside phosphorylase inhibitor 8-amino-9-benzylguanine in recipient tissues of canine renal allograft rejection.
    Yen CY; Lin CY
    J Surg Res; 1996 May; 62(2):260-6. PubMed ID: 8632649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal histopathologic assessment of rejection after bladder-drained canine pancreas allograft transplantation.
    Allen RD; Grierson JM; Ekberg H; Hawthorne WJ; Williamson P; Deane SA; Chapman JR; Stewart GJ; Little JM
    Am J Pathol; 1991 Feb; 138(2):303-12. PubMed ID: 1992759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delay of acute rejection of canine pancreatic allograft by ex vivo perfusion with anti-class II monoclonal antibody.
    Miyoshi K; Sakagami K; Orita K
    Transplant Proc; 1992 Aug; 24(4):1417-20. PubMed ID: 1496603
    [No Abstract]   [Full Text] [Related]  

  • 5. Local inhibition of major histocompatibility complex class II induction within the graft: an effective way to induce immunosuppression.
    Ruers TJ; Buurman WA; van der Linden CJ; Kootstra G
    Transplant Proc; 1987 Feb; 19(1 Pt 1):246-7. PubMed ID: 3152698
    [No Abstract]   [Full Text] [Related]  

  • 6. Donor pretreatment with IFN-gamma enhances MHC class II antigen expression and accelerates graft rejection by modified recipients.
    Ijzermans JN; Bouwman E; Jeekel J; Marquet RL
    Transplant Proc; 1990 Aug; 22(4):1941-2. PubMed ID: 2117821
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhancement of cytomegalovirus infection and acute rejection after allogeneic lung transplantation in the rat: virus-induced expression of major histocompatibility complex class II antigens.
    You XM; Steinmüller C; Wagner TO; Bruggeman CA; Haverich A; Steinhoff G
    J Heart Lung Transplant; 1996 Nov; 15(11):1108-19. PubMed ID: 8956120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of donor major histocompatibility complex antigens in coronary arterial vessels: mechanism of arterial vasculitis in rat allografts treated with cyclosporine.
    Herskowitz A; Tamura F; Ueda K; Neumann DA; Slepian M; Rose NR; Beschorner WE; Baumgartner WA; Reitz BR; Sell KW
    J Heart Transplant; 1989; 8(1):11-9. PubMed ID: 2647926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pattern of rejection and susceptibility to different kinds of immunosuppression after combined liver, duodenum, and pancreas transplantation in swine--immunosuppressive drugs versus ex vivo immunomodulation of the allograft.
    Saito S; Fujiwara T; Sakagami K; Kobayashi N; Takaishi Y; Orita K
    Transplant Proc; 1995 Feb; 27(1):518-9. PubMed ID: 7533420
    [No Abstract]   [Full Text] [Related]  

  • 10. The induction of class II antigens by interferon-gamma and its relevance for the acute rejection of allografts.
    IJzermans JN; Bouwman E; de Bruin RW; Marquet RL; Jeekel J
    Transplant Proc; 1987 Feb; 19(1 Pt 1):244-5. PubMed ID: 3152697
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo immunosuppressive effect of purine nucleoside phosphorylase inhibitor-8-amino-9-benzyl-guanine in canine renal allograft rejection.
    Lin CY; Yen CY
    Transplant Proc; 1994 Dec; 26(6):3126-7. PubMed ID: 7998091
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular analysis of graft survival in renal transplantation by DNA typing of HLA class II antigens.
    Tsuji K; Inoko H; Ando A; Matsuno N; Ikewaki N; Sato T; Ichikawa Y; Sonoda T
    Transplant Proc; 1987 Feb; 19(1 Pt 1):662-3. PubMed ID: 3152706
    [No Abstract]   [Full Text] [Related]  

  • 13. Expression of class I and class II major histocompatibility complex (MHC) antigens in rejecting human heart grafts.
    Ippoliti G; Lazzaro A; Goggi C; Malavasi F; Di Franco L; Martinelli L; Ascari E; Vigano' M
    Transplant Proc; 1989 Feb; 21(1 Pt 1):445-6. PubMed ID: 2650172
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimental transplantation and histocompatibility systems in the canine species.
    Rapaport FT; Bachvaroff RJ
    Adv Vet Sci Comp Med; 1978; 22():195-219. PubMed ID: 153705
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-TNF antibody modulates cytokine and MHC expression in cardiac allografts.
    Wei RQ; Schwartz CF; Lin H; Chen GH; Bolling SF
    J Surg Res; 1999 Feb; 81(2):123-8. PubMed ID: 9927530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cyclosporine-induced autoreactive T lymphocytes in solid organ allograft survival and chronic rejection.
    Zhang H; Horwitz L; Ruvolo P; Colombani P; Hess AD
    Transplantation; 1995 Jul; 60(2):115-22. PubMed ID: 7624952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of class II antigen: marker for rejection?
    O'Brien J; Horsburgh T; Veitch PS
    Transplant Proc; 1987 Feb; 19(1 Pt 1):211-2. PubMed ID: 3152689
    [No Abstract]   [Full Text] [Related]  

  • 18. Computer-assisted densitometric analysis for quantification of cell surface antigen expression in monkey cardiac allografts: correspondence to histopathologic grade of rejection.
    Kitamura M; Lackides GA; Billingham ME; Clayberger C; Starnes VA
    Transplant Proc; 1993 Feb; 25(1 Pt 2):924-7. PubMed ID: 8442269
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of ex vivo perfusion using anti-class II monoclonal antibody on the rejection of canine pancreaticoduodenal allografts.
    Miyoshi K; Sakagami K; Takasu S; Oiwa T; Kurozumi Y; Saito S; Yagi T; Kobayashi N; Fujiwara T; Matsuno T
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1600-3. PubMed ID: 1989304
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of class II major histocompatibility complex antigen expression for the differential diagnosis of cyclosporine A nephrotoxicity from kidney graft rejection.
    Barrett M; Milton AD; Barrett J; Taube D; Bewick M; Parsons VP; Fabre JW
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1769-71. PubMed ID: 3152634
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.